Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377

FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS

Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,337

Increased nigral iron content in postmortem parkinsonian brain

Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963

Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro

Graham, D. G., Tiffany, S. M., BELL, W. R., & Gutknecht, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953

The importance of free radicals and catalytic metal ions in human diseases.

Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941

Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation

Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709

Brain Peroxidase and Catalase in Parkinson Disease

Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404

Striatal Dopamine Dynamics Are Altered Following an Intranigral Infusion of Iron in Adult Rats

Lin, A. M. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00398-5 · Cited by 14

Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease

Costas‐Ferreira, C., & Faro, L. R. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210421092725 · Cited by 14

Arsenite induces oxidative injury in rat brain

Fan, S., Chao, P., & Lin, A. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05170.x · Cited by 13

Cu2+ ions modulate the interaction between α-synuclein and lipid membranes

Wang, H., Mörman, C., Sternke‐Hoffmann, R., Huang, C., Prota, A., Ma, P., & Luo, J. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.111945 · Cited by 13

Carbonic Anhydrase I, II, and VI, Blood Plasma, Erythrocyte and Saliva Zinc and Copper Increase After Repetitive Transcranial Magnetic Stimulation

Henkin, R. I., Velicu, I., Potolicchio, S. J., Levy, L. M., Martin, B. M., & Moharram, R. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181cda0e3 · Cited by 13

The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease

Sen, S., & West, A. B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2430 · Cited by 12

Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina

Shahandeh, A., Bui, B. V., Finkelstein, D. I., & Nguyen, C. T. O. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24685 · Cited by 13

Therapeutic potential of ATP-sensitive potassium channels in Parkinson’s disease

Zhao, S., Wang, M., & Ma, Z. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.01.003 · Cited by 16

PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons

Cristóvão, A. C., Barata, J. R., Je, G., & Kim, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.085 · Cited by 13

Genotype and allele frequencies of divalent metal transporter 1 polymorphism in Turkish population

Kayaaltı, Z., Odabaşi, M., & Söylemezoğlu, T. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0410-x · Cited by 13

Concentrations of some essential elements in the brain of aluminum-exposed rats in relation to the age of exposure

Gómez, M., Sánchez, D. J., Llobet, J. M., Corbella, J., & Domingo, J. L. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(96)00766-2 · Cited by 13

Serotonin binding proteins “SBP”: Target proteins and tool for in vitro neurotoxicity studies

Jiménez-Del-Río, M., Velez‐Pardo, C., Ebinger, G., & Vauquelin, G. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00063-1 · Cited by 13

The modern management of Parkinson's disease.

Quinn, N. P. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.2.93 · Cited by 13

Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation

Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Camp, D. M., Arnold, L. A., & Hyland, Κ. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00140-3 · Cited by 13

Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review

Chen, Y., Wu, Z., Li, S., Chen, Q., Wang, L., Qi, X., Tian, C., & Yang, M. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s458026 · Cited by 12

Mathematical approach to understand the kinetics of α-synuclein aggregation: Relevance to Parkinson's disease

Bharathi, P., Nagabhushan, P. N., & Rao, K. S. J. (2008) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2008.08.008 · Cited by 12

Free Radicals and Oxidative Stress in Neurodegenerative Disorders

Nigam, D. (2014) · Springer eBooks · doi:10.1007/978-81-322-2035-0_11 · Cited by 13

Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis

Panahi, H. K. S., Dehhaghi, M., Heng, B., Lane, D. J. R., Bush, A. I., Guillemin, G. J., & Tan, V. X. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00455-6 · Cited by 12

Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease

Jerez, P. Á., Alcantud, J. L., Reyes‐Ramírez, L. D. L., Moore, A. K., Ruz, C., Montero, F. V., Rodríguez-Losada, N., Saini, P., Gan‐Or, Z., Alvarado, C. X., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00496-y · Cited by 12

Is the 1254T>C polymorphism in the DMT1 gene associated with Parkinson’s disease?

Saadat, S. M., Değirmenci, İ., Özkan, S., Saydam, F., Köroğlu, Z. Ö., Çolak, E., & Güneş, H. V. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.054 · Cited by 12

Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?

Datta, I., & Bhonde, R. R. (2012) · Cell Biology International · doi:10.1042/cbi20110602 · Cited by 12

Repeatedly heated mix vegetable oils-induced atherosclerosis and effects of Murraya koenigii

Gul, A., Siddiq, A., Hussain, K., Hussain, A. S., & Naz, Z. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03012-4 · Cited by 12

Neurometabolic profiles of the substantia nigra and striatum of MPTP‐intoxicated common marmosets: An in vivo proton MRS study at 9.4 T

Heo, H., Ahn, J., Lee, H. H., Kwon, E., Yun, J., Kim, H., & Kang, B. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3686 · Cited by 12

Intranigral iron infusion in rats: A progressive model for excess nigral iron levels in Parkinson’s disease?

Arendash, G. W., Olanow, C. W., & Sengstock, G. J. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_8 · Cited by 12

Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system

Nakamura, K., Won, L., Heller, A., & Kang, U. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02425-2 · Cited by 12

Modifications of the Synaptosomal Dopamine Uptake and Release by Two Systems Generating Free Radicals: Ascorbic Acid/Fe2+and l ‐Arginine/NADPH

Ramassamy, C., Girbe, F., Pincemail, J., Christen, Y., & Costentin, J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21799.x · Cited by 12

The neurotoxic component in Parkinson’s disease may involve iron-melanin interaction and lipid peroxidation in the substantia nigra

Youdim, M. B. H., & Ben‐Shachar, D. (1990) · New vistas in drug research · doi:10.1007/978-3-7091-9098-2_13 · Cited by 12

Parkinson’s Disease

Burke, R. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_22 · Cited by 12

Ferroptosis inhibition protects against α-synuclein-related neuronal cell death

Majerníková, N., Caiado, M. J. D. C., Seinstra, R. I., Couzijn, S., Goya, M. E., Salinas, C. S., Truong, H., van der Sluis, T., Miedema, A., van Kempen, L. C. L. T., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08319-z · Cited by 11

Ion Channels and Metal Ions in Parkinson’s Disease: Historical Perspective to the Current Scenario

Vaidya, B., Padhy, D. S., Joshi, H. C., Sharma, S. S., & Singh, J. N. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_36 · Cited by 11

Association study of the G258S transferrin gene polymorphism and Parkinson's disease in the Spanish population

Ezquerra, M., Campdelacreu, J., Muñóz, E., & Tolosa, E. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0695-1 · Cited by 11

Iron as a risk factor in neurological diseases

Gałązka-Friedman, J. (2008) · Hyperfine Interactions · doi:10.1007/s10751-008-9723-8 · Cited by 11

La Enfermedad de Parkinson: Etiología, Tratamientos y Factores Preventivos

Hurtado, F., Cardenas, M. A. N., Cárdenas, F. P., & León, L. A. (2017) · Universitas Psychologica · doi:10.11144/javeriana.upsy15-5.epet · Cited by 11

The effect of the stoichiometric ratio of zinc towards the fibrillation of Bovine Serum Albumin (BSA): A mechanistic insight

Roy, A., Tiwari, S., Karmakar, S., Reddy, K. A., & Pandey, L. M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.120 · Cited by 12

From niche methods to necessary tools: The growing importance of analytical atomic spectrometry in metal imaging in neuroscience

McAllum, E. J., & Hare, D. J. (2019) · Spectrochimica Acta Part B Atomic Spectroscopy · doi:10.1016/j.sab.2019.04.009 · Cited by 11

Rhodamine‐Based Fluorescence ‘Turn‐On’ Chemosensor: Detection of Fe 3+ Ion in Aqueous Medium and MCF‐7 Live Cells

Badekar, P. S., Thakur, G. C. N., Varma, M. E., Ghatpande, N., Kulkarni, P. P., & Kumbhar, A. A. (2021) · ChemistrySelect · doi:10.1002/slct.202004640 · Cited by 11

Association between Anemia and Risk of Parkinson Disease

Wang, Y., Huang, A. P., Yuan, S., Huang, C.-Y., Wu, C.-C., Poly, T. N., Atique, S., & Kung, W. (2021) · Behavioural Neurology · doi:10.1155/2021/8360627 · Cited by 12

Levels of α‐ and β‐synuclein regulate cellular susceptibility to toxicity from α‐synuclein oligomers

Angelova, D. M., Jones, H. B. L., & Brown, D. R. (2017) · The FASEB Journal · doi:10.1096/fj.201700675r · Cited by 12

Prevention and Therapy of Neurodegenerative Disorders: Role of Nutritional Antioxidants

Matteo, V. D., Pierucci, M., Giovanni, G. D., & Esposito, E. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50168-x · Cited by 11

Ferritin in the cerebrospinal fluid of patients with Parkinson's disease.

Pall, H., Brailsford, S., Williams, A. C., Lunec, J., & Blake, D. R. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.9.803 · Cited by 11

REVIEW ARTICLE: FREE RADICALS, ANTIOXIDANTS AND HUMAN DISEASE: WHERE ARE WE NOW?

Halliwell, B. B., Gutteridge, J. M. C., & Cross, C. E. (1992) · Cited by 11

Neurological Disease

Muller, D. P. R. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60999-0 · Cited by 11

Iron deposits in brain disorders

Jellinger, K. A., & Kienzl, E. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_2 · Cited by 11

MR imaging of putamenal iron predicts response to dopaminergic therapy in parkinsonian patients

Olanow, C. W., Alberts, M. J., Djang, W. T., & Stajich, J. M. (1990) · New vistas in drug research · doi:10.1007/978-3-7091-9098-2_12 · Cited by 11

Lable-Free LSPR-Based Colorimetric Detection of α-Synuclein, a Biomarker of Parkinson’s Disease, in Saliva

Mottaghi, A., Nikkhah, M., & Masroor, M. J. (2023) · IEEE Sensors Journal · doi:10.1109/jsen.2023.3239887 · Cited by 11

Murraya koenigii (Curry Tree): A review of its Phytochemistry, Ethnomedicinal uses, and Pharmacology with Respect to Molecular Mechanisms

Patil, R., Mandlik, S. K., & Mandlik, D. S. (2023) · Current Traditional Medicine · doi:10.2174/2215083810666230609163404 · Cited by 10

Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s Disease

Sobral, J., Empadinhas, N., Esteves, A. R., & Cardoso, S. M. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae208 · Cited by 12

Differences between conventional and non conventional MRI techniques in Parkinson�s disease

Baglieri, A. (2013) · Functional Neurology · doi:10.11138/fneur/2013.28.1.073 · Cited by 10

[The role of ferroptosis in chronic diseases].

Chen, J., Xiang, Y., Fang, X., Wang, F., & Min, J. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.02.24 · Cited by 11

Single-molecule nanopore dielectrophoretic trapping of α-synuclein with lipid membranes

Wu, J., Yamashita, T., Hamilton, A. D., Thompson, S., & Luo, J. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2022.101243 · Cited by 10

Oxidative Inactivation of Brain Alkaline Phosphatase Responsible for Hydrolysis of Phosphocholine

Sok, D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720355.x · Cited by 10

Tracemetals, neuromelanin and neurodegeneration: An interesting area for research

Rao, T. S., Zecca, L., & Rao, K. J. (2007) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.37310 · Cited by 10

MANAGEMENT OF EARLY PARKINSON'S DISEASE

Hauser, R. A., & Zesiewicz, T. A. (1999) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70111-5 · Cited by 10

In vivo imaging markers of neurodegeneration of the substantia nigra

Auer, D. P. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.08.051 · Cited by 10

Cell Death and Disease

Xu, K. (2022) · Biochemistry · doi:10.5772/intechopen.104360 · Cited by 9

Ferritin Is Secreted from Primary Cultured Astrocyte in Response to Iron Treatment via TRPML1-Mediated Exocytosis

Yu, X., Xiao, Z., Xie, J., & Xu, H. (2023) · Cells · doi:10.3390/cells12212519 · Cited by 9

Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects

Fornstedt, B. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-023-02718-2 · Cited by 10

Iron toxicity, ferroptosis and microbiota in Parkinson’s disease: Implications for novel targets

Carvalho, F. V., Landis, H. E., Getachew, B., da Silva, V. D. A., ribeiro, P. R. R., Aschner, M., & Tizabi, Y. (2024) · Advances in neurotoxicology · doi:10.1016/bs.ant.2024.02.001 · Cited by 9

HFE Mutations in Neurodegenerative Disease as a Model of Hormesis

Marshall, S., & Connor, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063334 · Cited by 10

A Review on Therapeutic Strategies against Parkinson’s Disease: Current Trends and Future Perspectives

Papagiouvannis, G., Theodosis‐Nobelos, P., & Rekka, E. A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575303788240606054620 · Cited by 10

In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease

Yeager, M. P., & Coleman, R. A. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.01.034 · Cited by 9

The delivery of tyrosine hydroxylase accelerates the neurorestoration of Macaca Rhesus model of Parkinson's disease provided by Neurturin

Wang, W., Sun, M., Li, H., Wang, W., & Yan, M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.063 · Cited by 9

Proceedings: Cell Therapies for Parkinson's Disease From Discovery to Clinic

Canet-Aviles, R., Lomax, G. P., Feigal, E. G., & Priest, C. A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0146 · Cited by 9

The Extracellular Zn2+ Concentration Surrounding Excited Neurons Is High Enough to Bind Amyloid‐β Revealed by a Nanowire Transistor

Anand, A., Chi, C., Banerjee, S., Chou, M., Tseng, F., Pan, C., & Chen, Y. (2018) · Small · doi:10.1002/smll.201704439 · Cited by 9

Dopamin, oxidativer Stress und Protein‐Chinonmodifikationen bei Parkinson und anderen neurodegenerativen Erkrankungen

Monzani, E., Nicolis, S., Dell’Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2018) · Angewandte Chemie · doi:10.1002/ange.201811122 · Cited by 9

Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

Walsh, S., Gavin, A. M., Wyatt, S. L., O'Connor, C., Keeshan, K., Nolan, Y. M., O’Keeffe, G. W., & Sullivan, A. M. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.904304 · Cited by 9

Magnetic Resonance Imaging of Brain Iron

Bartzokis, G. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_3 · Cited by 9

Therapeutic iron-chelating agents

SINGH, S., & Hider, R. C. (1994) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60443-3 · Cited by 9

Molecular and Cellular Events Regulating Dopamine Neuron Survival

Corsini, G. U., Maggio, R., & Vaglini, F. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_11 · Cited by 9

Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism

Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 12

Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target

Mitra, R. S., Premraj, L., & Khoo, T. K. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105448 · Cited by 8

Empirically derived formulae for calculation of age- and region-related levels of iron, copper and zinc in the adult C57BL/6 mouse brain

Suryana, E., Rowlands, B. D., Bishop, D., Finkelstein, D. I., & Double, K. L. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.01.003 · Cited by 8

Determination of metal elements concentrations in human brain tissues using PIXE and EDX methods

Pánik, J., Kopáni, M., Zeman, J., Jeskovsky, M., Kaizer, J., & Povinec, P. P. (2018) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-018-6208-3 · Cited by 8

OXIDATIVE STRESS AND PARKINSON DISEASE

Nikolova, G. (2012) · Cited by 8

Neuroprotective effects of Wharton's jelly-derived mesenchymal stem cells on motor deficits due to Parkinson's disease.

Jalali, M. S., Sarkaki, A., Farbood, Y., Azandeh, S. S., Mansouri, E., Dehcheshmeh, M. G., & Saki, G. (2021) · PubMed Central · doi:10.22038/ijbms.2021.54091.12159 · Cited by 8

Levels of serum trace elements in ischemic stroke patients

Gönüllü, H., Karadaş, S., Milanlıoğlu, A., Gönüllü, E., Katı, C., & Demir, H. (2014) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.30.04.004 · Cited by 8

Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson’s Disease: Epicenter or Outcome, Yet a Demigod Question

Rasheed, M. S. U., Tripathi, S., Mishra, S., & Singh, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0016-y · Cited by 5

Systems Genetics Analysis of Iron and Its Regulation in Brain and Periphery

Jones, B. C., & Jellen, L. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6427-7_22 · Cited by 8

The Advances of Nanozyme in Brain Disease

Zhang, R., Yan, X., & Fan, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_6 · Cited by 8

Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra

Zecca, L., Tampellini, D., Costi, P., Rizzio, E., Giaveri, G., & Gallorini, M. (2001) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1013251510671 · Cited by 8

Role of Selenium, Iron, Copper, and Zinc in Parkinsonism

Qureshi, G. A., Syed, S. A., & Parvez, S. H. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50171-x · Cited by 8

Zinc modulates GABAergic neurotransmission in rat globus pallidus

Chen, L., & Yung, W. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.033 · Cited by 8

Oxidative stress, brain iron and neurodegeneration. Basic principles

Gutteridge, J. M. C., & Halliwell, B. B. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50003-5 · Cited by 8

Parkinson's disease

Korlipara, L. V. P., & Schapira, A. H. V. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53011-7 · Cited by 8

Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases

Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8

Nuclear microscopic investigations into the elemental changes in the substantia nigra of unilaterally MPTP-lesioned Parkinsonian monkeys

Thong, P. S. P., He, Y., Lee, T., & Watt, F. (1997) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/s0168-583x(97)00239-5 · Cited by 8

Reduction of 13-Hydroperoxy-9,11-octadecadienoic Acid by Dopamine-Melanin

ȩ, K. S., Zajdel, A., Swierczek-Zieba, G., Wilczok, A., & Wilczok, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7678 · Cited by 8

Lipidomic and Metallomic Alteration of Caenorhabditis elegans after Acute and Chronic Manganese, Iron, and Zinc Exposure with a Link to Neurodegenerative Disorders

Blume, B., Schwantes, V., Witting, M. A., Hayen, H., Schmitt‐Kopplin, P., Helmer, P. O., & Michalke, B. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00578 · Cited by 7

Realizing brain therapy with “smart medicine”: mechanism and case report of molecular hydrogen inhalation for Parkinson’s disease

Ichikawa, Y., Sato, B., Hirano, S., Takefuji, Y., & Satoh, F. (2023) · Medical Gas Research · doi:10.4103/2045-9912.385949 · Cited by 7

Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinson’s Disease from Essential Tremor and Healthy Individuals

Bienes, G. H. A. A., Zorzenon, C. D. P. F., Alves, E. D., Tibana, L. A. T., Borges, V., Carrete, H., & Ferraz, H. B. (2021) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.604 · Cited by 7

Quantification of Paramagnetic Ions in Human Brain Tissue Using EPR

Otsuka, F. S., Otaduy, M. C. G., Nascimento, O. R., & Salmón, C. E. G. (2022) · Brazilian Journal of Physics · doi:10.1007/s13538-022-01098-4 · Cited by 7

Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease

Khedher, L., Bonny, J.-M., Marquès, A., Durand, E., Pereira, B., Marie Chupin, A., Vidal, T., Chassain, C., Defebvre, L., Carrière, N., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103231 · Cited by 7

A Novel Mitochondria-Targeting Iron Chelator Neuroprotects Multimodally via HIF-1 Modulation Against a Mitochondrial Toxin in a Dopaminergic Cell Model of Parkinson’s Disease

Fouché, B. R., Turner, S., Gorham, R., Stephenson, E. J., Gutbier, S., Elson, J. L., García‐Beltrán, O., van der Westhuizen, F. H., & Pienaar, I. S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03107-8 · Cited by 7

Butyrate Protects and Synergizes with Nicotine against Iron- and Manganese-induced Toxicities in Cell Culture

Tizabi, Y., Getachew, B., & Aschner, M. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00682-z · Cited by 7

Effect of L-dopa, oxyferriscorbone and ferrous iron on in vivo lipid peroxidation

Dostert, P., Benedetti, M. S., & Frigerio, E. (1991) · Journal of Neural Transmission · doi:10.1007/bf01249115 · Cited by 7

Preliminary observations of transverse relaxation rates obtained at 3 Tesla from the substantia nigra of adult normal human brain

Helpern, J. A., Gorell, J. M., Deniau, J. C., Welch, K. M. A., & Ordidge, R. J. (1995) · NMR in Biomedicine · doi:10.1002/nbm.1940080106 · Cited by 7

Etiology and pathogenesis of Parkinson disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00005-6 · Cited by 8

Environmental Risk Factors for Parkinson’s Disease

Gorell, J. M., & Rybicki, B. A. (2003) · CRC Press eBooks · doi:10.1201/9780203912164-19 · Cited by 7

Abnormal iron metabolism in the zona incerta in Parkinson’s disease mice

Xiu, M., Liu, Y., Wang, Z., Zhang, J., Shi, Y., Xie, J., & Shi, L. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02913-3 · Cited by 6

Midbrain and pallidal iron changes identify patients with REM sleep behaviour disorder and Parkinson’s disease

Alushaj, E., Kuurstra, A. B., Menon, R. S., Ganjavi, H., Morava, A., Sharma, M., Kashgari, A., Barr, J., Reisman, W. M., KHAN, A. R., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00916-1 · Cited by 6

Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats

Tarohda, T., Ishida, Y., Kawai, K., Yamamoto, M., & Amano, R. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-3423-x · Cited by 95

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain

Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 126

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

Dexter, D. T., Jenner, P. G., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537